L932-0253 Screening compound: methyl 2-({[1-(4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)piperidin-4-yl]carbamoyl}amino)-3-phenylpropanoate

L932-0253 Screening compound: methyl 2-({[1-(4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)piperidin-4-yl]carbamoyl}amino)-3-phenylpropanoate
L932-0253 Screening compound: methyl 2-({[1-(4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)piperidin-4-yl]carbamoyl}amino)-3-phenylpropanoate alternative view

Chemical Structure Depiction of ChemDiv screening compound L932-0253
methyl 2-({[1-(4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)piperidin-4-yl]carbamoyl}amino)-3-phenylpropanoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L932-0253

Molecular Formula

C25H29N5O4 (C25 H29 N5 O4)

Compound Name

methyl 2-({[1-(4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)piperidin-4-yl]carbamoyl}amino)-3-phenylpropanoate

IUPAC name

methyl 2-({[1-(4-methyl-3-oxo-34-dihydroquinoxalin-2-yl)piperidin-4-yl]carbamoyl}amino)-3-phenylpropanoate

SMILES

CN(c(cccc1)c1N=C1N(CC2)CCC2NC(NC(Cc2ccccc2)C(OC)=O)=O)C1=O

InChI

InChI=1S/C25H29N5O4/c1-29-21-11-7-6-10-19(21)27-22(23(29)31)30-14-12-18(13-15-30)26-25(33)28-20(24(32)34-2)16-17-8-4-3-5-9-17/h3-11,18,20H,12-16H2,1-2H3,(H2,26,28,33)/t20-/m0/s1

InChI Key

QUBUHYOYDBWNNB-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD15137476

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

463.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.622

Distribution Coefficient, logD

1.622

Water Solubility, LogSw

-1.88

Polar Surface Area

81.542

Acid Dissociation Constant (pKa)

14.78

Base Dissociation Constant (pKb)

5.83

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.00

L932-0253 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Integrin Receptors Targeted library (1715 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Others

References: we are preparing a list of scientific research reports with L932-0253 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L932-0253?
Check Price and Availability of L932-0253, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L932-0253 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L932-0253
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L932-0253
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L932-0253 available by request